- Home
- ISRG vs BSX Comparison
ISRG vs BSX Comparison
Compare ISRG & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISRG
- BSX
- Stock Information
- Founded
- ISRG 1995
- BSX 1979
- Country
- ISRG United States
- BSX United States
- Employees
- ISRG N/A
- BSX N/A
- Industry
- ISRG Medical/Dental Instruments
- BSX Medical/Dental Instruments
- Sector
- ISRG Health Care
- BSX Health Care
- Exchange
- ISRG Nasdaq
- BSX Nasdaq
- Market Cap
- ISRG 154.0B
- BSX 157.6B
- IPO Year
- ISRG 2000
- BSX 1992
- Fundamental
- Price
- ISRG $457.93
- BSX $100.32
- Analyst Decision
- ISRG Buy
- BSX Strong Buy
- Analyst Count
- ISRG 16
- BSX 22
- Target Price
- ISRG $588.07
- BSX $121.09
- AVG Volume (30 Days)
- ISRG 2.2M
- BSX 10.2M
- Earning Date
- ISRG 10-21-2025
- BSX 10-22-2025
- Dividend Yield
- ISRG N/A
- BSX N/A
- EPS Growth
- ISRG 23.20
- BSX 36.90
- EPS
- ISRG 7.17
- BSX 1.68
- Revenue
- ISRG $9,145,000,000.00
- BSX $18,494,000,000.00
- Revenue This Year
- ISRG $19.57
- BSX $19.85
- Revenue Next Year
- ISRG $14.45
- BSX $11.07
- P/E Ratio
- ISRG $62.23
- BSX $59.07
- Revenue Growth
- ISRG 20.77
- BSX 21.44
- 52 Week Low
- ISRG $425.00
- BSX $80.64
- 52 Week High
- ISRG $616.00
- BSX $109.50
- Technical
- Relative Strength Index (RSI)
- ISRG 55.71
- BSX 56.51
- Support Level
- ISRG $427.84
- BSX $94.53
- Resistance Level
- ISRG $440.82
- BSX $99.61
- Average True Range (ATR)
- ISRG 11.16
- BSX 2.30
- MACD
- ISRG 2.29
- BSX 0.65
- Stochastic Oscillator
- ISRG 83.31
- BSX 93.97
About ISRG Intuitive Surgical Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.